Why the study?
Does percutaneous coronary intervention with drug-eluting stents compared to coronary bypass surgery improve clinical outcomes in patients with coronary artery disease?
Does percutaneous coronary intervention with drug-eluting stents compared to coronary bypass surgery improve clinical outcomes in patients with coronary artery disease?
Answers are grounded in this paper and cite their sources.
At 5 years, CABG offers a clinically relevant benefit over DES-PCI for mortality, MI, and repeat revascularization in patients with coronary artery disease, though it carries a higher risk of stroke.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kawczyński et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: